Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: taVNS on Functional Mobility in People With DP [Phase 2]

View source ↗

Summary

Phase 2 study evaluating transcutaneous auricular vagus nerve stimulation (taVNS) for improving functional mobility in people with Parkinson's disease; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taVNS (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: Universidade Federal de Pernambuco | Conditions: PARKINSON DISEASE (Disorder) | Phase 2 | Status: NOT_YET_RECRUITING